Content area

|
|

Behandling af synstruende diabetisk retinopati

Forfatter(e)
Jakob Grauslund1, 2 1) Øjenafdeling E, Odense Universitetshospital 2) Forskningsenheden for Oftalmologi, Klinisk Institut, Syddansk Universitet Ugeskr Læger 2018;180:V11170870
Reference: 
Ugeskr Læger 2018;180:V11170870
Sidetal: 
2-5
Treatment of sight-threatening diabetic retinopathy
In diabetic retinopathy, treatment is indicated for sight-threatening complications like proliferative diabetic retinopathy (PDR) and diabetic macular oedema (DME). For decades, treatment has been with panretinal laser for PDR and focal/grid laser for DME. In recent years, intravitreal therapy with vascular endothelial growth factor (VEGF) inhibition or steroids has replaced laser treatment in centre-involving DME. Intravitreal VEGF-inhibition has also demonstrated effectiveness in PDR, but long-term studies are needed to address the concern of a potential continuous treatment burden.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Frederik Liljefred | 23/10
1 Kommentar
af Kirsten Anne M. Olesen | 23/10
3 kommentarer
af Else Lyngsøe Svejgaard | 23/10
3 kommentarer
af Camilla Bang | 21/10
3 kommentarer
af Anne Gersdorff Korsgaard | 20/10
1 Kommentar
af Karen Brink Linnet | 19/10
1 Kommentar
af Thor Andersen Knudsen | 19/10
2 kommentarer
af Ole Lindgård Dollerup | 18/10
1 Kommentar
af Kristine Rasmussen | 18/10
1 Kommentar